Skip to main content
. Author manuscript; available in PMC: 2013 Mar 7.
Published in final edited form as: Clin Lymphoma Myeloma Leuk. 2011 Aug;11(4):367–372. doi: 10.1016/j.clml.2011.06.005

Table 4.

Percentage Activated (CD69+) Vs. Nonactivated (CD69) T Lymphocytes That Express CD39

Variable CD3+/CD69+(SD) CD3+/CD69
% CD39+ 28.9 (20.4) 15.0a (7.2)
*

P < .05 for comparison, with N = 12 samples examined.